PURPOSE: To provide a personal perspective concerning diagnosis, treatment, and
evaluation of treatment for early and late stages of age-related macular degeneration (AMD) …

Age-related macular degeneration (AMD) is the leading cause of irreversible visual loss in
the USA. Laser photocoagulation of choroidal neovascular membranes (CNVMs) in …

Inflammation protects from dangerous stimuli, restoring normal tissue homeostasis.
Inflammatory response in the nervous system (“neuroinflammation”) has distinct features …

Age-related macular degeneration (AMD) is a leading cause of blindness in people over the
age of 55. Despite its common nature, the etiology of the disease involves both genetic and …

Considerable advances have been made in our understanding of age-related macular
degeneration (AMD) genetics over the past decade. The genetic associations discovered to …

The study of epigenetics has explained some of the 'missing heritability'of age-related
macular degeneration (AMD). The epigenome also provides a substantial contribution to the …

Age related macular degeneration (AMD) is an extremely prevalent complex genetic
disorder. Its incidence rises exponentially in the elderly to a frequency of 1 in 2 in the …

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in the
older population. Classical hallmarks of early and intermediate AMD are accumulation of …

Neovascular age-related macular degeneration (AMD) is a complex disease in which an
individual's genetic predisposition is affected by aging and environmental stresses, which …

Age-related macular degeneration (AMD) is the leading cause of severe vision loss in
individuals over the age of 50 years. Choroidal neovascularization (CNV) is the hallmark of …